Ranchi: Considered a game changer in the treatment of Covid-19 patients, the antibody cocktail is now available at the Raj Hospital and Research Centre in Ranchi. The cocktail of two monoclonal antibodies — casirivimab and imdevimab — can be used on mild and moderate Covid patients and is known to reduce the chances of hospitalization by 70%. The proprietor of Raj Hospital, Jogesh Gambhir, said the medical fraternity was eagerly waiting for this ‘wonder drug’ to arrive in India after the Centre granted emergency-use authorisation. “It arrived in Delhi on May 26 and we are the first in Jharkhand to obtain the consignment. Although the single-dose drug is costly and priced at around Rs 60,000, we are hopeful that people in the high-risk groups can be prevented from slipping into emergency condition by the use of this drug,” Gambhir said.